TAKE logo

TAKE share news, announcements and annual reports

NSE: TAKEBSE: 532890Healthcare ServicesSmall Cap

TAKE Limited · Formerly Take Solutions · Face value ₹1 · Listed Aug 2007
Last close ₹11.06up ₹0.52 (4.93%)BSE ₹11.13

Share price at the NSE close on 29 Oct 2026. Previous close ₹10.54.

29 Oct: open ₹10.96, high ₹11.06, low ₹10.38

52-week range of traded prices to 29 Oct 2026
₹9.88Low, 27 Oct 2026₹50.14High, 20 Apr 2026
Market cap
₹164 Cr1,780th largest listed
P/E
12.76
P/E without one-offs
27.71
P/B
5.28
Dividend yield
Nonein the last 12 months
ROE
49.8%
ROE without one-offs
22.9%
ROCE
−5.6%
Debt to equity
0.00
Volume, NSE
2,94,38056.2% delivered

TAKE board meetings

137 filed, newest first. Page 2 of 3.

  1. Feb 2021

  2. Nov 2020

  3. Sep 2020

  4. Jun 2020

  5. Feb 2020

  6. Nov 2019

  7. Oct 2019

  8. Aug 2019

  9. May 2019

  10. Mar 2019

  11. Feb 2019

  12. Oct 2018

  13. Aug 2018

  14. May 2018

  15. Mar 2018

  16. Feb 2018

  17. Jan 2018

  18. Nov 2017

  19. Oct 2017

  20. Aug 2017

  21. May 2017

  22. Feb 2017

  23. Jan 2017

  24. Oct 2016

  25. Jul 2016

  26. May 2016

  27. Jan 2016

  28. Nov 2015

  29. Oct 2015

  30. Jul 2015

  31. May 2015

  32. Jan 2015

    • 23 Jan · Board meeting

      To consider and take on records, inter alia, the Unaudited Financial Statements for the quarter ended December 31, 2014.
  33. Nov 2014

    • 3 Nov · Board meeting

      To consider and take on records, inter alia, the Unaudited Financial Statements for the quarter and half year ended September 30, 2014.
  34. Jul 2014

    • 24 Jul · Board meeting

      To consider and take on record, inter alia, the Unaudited Financial Statements for the quarter ended June 30, 2014.
  35. May 2014

  36. Jan 2014

  37. Oct 2013

  38. Jul 2013

    • 22 Jul · Board meeting

      To consider and take on record, inter alia, the unaudited financial statements of the Company for the quarter ended June 30, 2013.
  39. May 2013

    • 14 May · Board meeting

      To consider and take on record, inter alia, the Audited Financial Statement & Accounts of the Company together with the Reports thereon for the Financial Year ended on March 31, 2013 and also to consider recommendation of Dividend, if any.